Covid Vaccine Race

In a move being ill-received by clinicians, the COVID-19 vaccine producer is lessening the count of vials being supplied to the government through July.

Project aims for additional good-paying jobs, combatting the climate crisis, advancing racial equity, and building back better than before.

If the current recommended dosing schedules for the vaccines are not “feasible,” then the agency said vaccines may be scheduled for administration up to 42 days between the first and second doses.

In organizations with 50 or fewer employees, an average of only 29% of healthcare workers had been offered the vaccine.

The US tops the list of total vaccine administrations despite a lagging rollout and ongoing issues.

Current trial evidence is severely lacking for the at-risk group, but does clinical history suggest safety?

An interview on new survey data suggesting a majority of fertility and pregnant patients are not interested in the currently available vaccines.

State and federal officials confirmed Friday that promise for a reserve supply of vaccines meant for second doses is actually unavailable.

The American College of Physicians offered recommendations on the distribution and administration of vaccines.

This vaccine is meant to be delivered as a single dose administration as compared to other vaccines that have been authorized and in development that require a booster shot.

The Department of Health and Human Services is expected to announce the new guidelines at noon.

Newly published data shows just 0.6% of patients receiving the Moderna mRNA vaccine reported serious adverse events, a rate identical to that of the placebo group.

China has overtaken the US and is currently leading all countries in total vaccine administrations.

The agency warns SARS-CoV-2 mutations can trigger potential false negative results in molecular tests.

The international organization offers guidance on various groups and if they should be consider getting the vaccine.

In vitro data suggest the more transmissible mutations of the virus are nonetheless prevented by the mRNA vaccine.

The federal agency announces that of nearly 2 million vaccinations, only 21 total cases of severe reactions took place.

Chinese company’s investigational vaccine reported to be 78% effective.

European Medicines Agency exercises its option for increasing the confirmed order commitment by 80 million doses, bringing total to 160 million.

Allergists offer risk stratification approach to avoid rare allergic reaction to COVID-19 vaccines

The US and the world must appreciate the role of the pharmaceutical industry—the investigators, physicians and business leaders—who are rescuing the world from COVID-19. It’s the medical breakthrough of our lifetime.

In the first week of 2021, the US is currently leading all countries in total vaccine administrations, despite state-level distribution setbacks.

From vaccine studies to reopening institutions, pooled testing may be a hugely beneficial tool.

The global health agency provided current insights and advisories into 4 different variants observed during COVID-19 this year.

The newly published data show no patient given the two-dose mRNA vaccine has yet to report a case of severe COVID-19.

Though regulatory authorization has not been granted, the company intends to vaccinate up to 50 million people prior to the Lunar New Year.

The authorization recommends dosage intervals of between 4 and 12 weeks.

Trial to enroll up to 30000 volunteers across approximately 115 sites in the US and Mexico.

With the public beginning to get vaccinated, CDC published information for people in some medical categories and considerations on severe allergic reactions.